Safdar, Adeel
Saleem, Ayesha
Tarnopolsky, Mark A.
Article History
First Online: 27 May 2016
Competing interests
: M.A.T. has an equity stake in Exerkine Corporation. M.A.T. is the Chief Executive Officer and President, and A. Safdar is the Chief Scientific Officer of Exerkine Corporation. Exerkine has filed patents for the use of exerkines and exersomes to treat metabolic disease, and the use of exosomes to treat genetic disorders.